Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-08-11

Clinical Trial Update: Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication [Phase 4]

View source ↗

Summary

Phase 4 trial update on resynchronization therapy in paced heart failure patients with ICD indication; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Schuechtermann-Klinik | Conditions: Heart Failure, Left Bundle-Branch Block | Phase 4 | Status: UNKNOWN